CureVac NV Sustainability Reports
CureVac N.V. is a global biopharmaceutical company that develops transformative medicines and therapies based on messenger ribonucleic acid (mRNA) technology. Its pipeline focuses primarily on prophylactic vaccines and cancer immunotherapies.
Sector: Manufacturing
Country: Germany
Exchange: Nasdaq
LEI: 724500BUT8GAG9LMYN56
FIGI: BBG00W9LXY93
4 reports from 2021 to 2024
